Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Berberine for prevention and treatment of chemotherapy-induced diarrhea in colorectal cancer
ChiCTR2300078353Phase 4Recruiting
- Sponsor
- The Second Affiliated Hospital of Zhejiang Chinese Medical University
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in diarrhea comparing Berberine group with Placebo group (2 arms). Primary endpoint: Incidence of chemotherapy-induced diarrhea grade 3 or higher from months 1 to 6. Started Dec 2023; status: recruiting.
02
Drugs
berberine
03
Conditions
diarrhea
Beyond the preview
Go deeper on ChiCTR2300078353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300078353.